Latest Articles
Organon Halts Development of Endometriosis Drug OG-6219 After Mid-Stage Trial Failure - geneonline.com
Organon Halts Development of Endometriosis Drug OG-6219 After Mid-Stage Trial Failure geneonline.com
Published: July 10, 2025, 8:10 a.m.
Co-occurrence of endometriosis with psoriasis and psoriatic arthritis: Genetic insights (Review).
Immunological factors appear to play an important role in the development of endometriosis, as evidenced by the aberrant functioning of immune cells often observed in affected women. Although endometriosis is …
Published: July 10, 2025, midnight
Organon to halt development of endometriosis pain drug after mid-stage trial failure - MSN
Organon to halt development of endometriosis pain drug after mid-stage trial failure MSN
Published: July 3, 2025, 10:49 p.m.
Organon abandons endometriosis pain drug development after trial failure - MSN
Organon abandons endometriosis pain drug development after trial failure MSN
Published: July 3, 2025, 4:01 p.m.
Organon drops OG-6219 development following trial miss - The Pharma Letter
Organon drops OG-6219 development following trial miss The Pharma Letter
Published: July 3, 2025, 10:55 a.m.
Karolinska Development receives update from Organon concerning OG-6219 - The Manila Times
Karolinska Development receives update from Organon concerning OG-6219 The Manila Times
Published: July 3, 2025, 5:03 a.m.
Organon Discontinues Endometriosis Drug Development After Failed Phase 2 Trial - Femtech Insider
Organon Discontinues Endometriosis Drug Development After Failed Phase 2 Trial Femtech Insider
Published: July 2, 2025, 9:17 p.m.
Organon to halt development of endometriosis pain drug after mid-stage trial failure - whbl.com
Organon to halt development of endometriosis pain drug after mid-stage trial failure whbl.com
Published: July 2, 2025, 9:02 p.m.
Organon Drops Drug Development For Endometriosis Pain After Mid-Stage Study Fails To Show Results By Stocktwits - Investing.com India
Organon Drops Drug Development For Endometriosis Pain After Mid-Stage Study Fails To Show Results By Stocktwits Investing.com India
Published: July 2, 2025, 5:15 p.m.
Organon Drops Drug Development For Endometriosis Pain After Mid-Stage Study Fails To Show Results - Stocktwits
Organon Drops Drug Development For Endometriosis Pain After Mid-Stage Study Fails To Show Results Stocktwits
Published: July 2, 2025, 4:43 p.m.
Link copied to clipboard!